News
Purdue University is launching new academic programs, expanding research capabilities and forging partnerships with one ...
The Tobias-Lechleiter Institute for Clinical Innovation will serve as a hub for "groundbreaking" disease detection and ...
A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...
Bucks County, Pa. has initiated legal proceedings against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated effort to inflate ...
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...
Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Where to invest $1,000 ...
Explore more
The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...
A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...
Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...
Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results